Whilst 3-FEA has not been formally analyzed on a similar stage as common amphetamines, it really is at present assumed that like other substituted amphetamines with substitutions at equivalent positions, it most likely acts largely like a triple reuptake inhibitor and/or releaser from the monoamine neurotransmitters serotonin, dopamine, and norepin